Earnings summaries and quarterly performance for RadNet.
Executive leadership at RadNet.
Howard Berger
President and Chief Executive Officer
Cornelis Wesdorp
President and Chief Executive Officer - Digital Health
David Katz
Executive Vice President, Chief Legal Officer and Corporate Secretary
Gregory Sorensen
Executive Vice President, Chief Science Officer
Mark Stolper
Executive Vice President and Chief Financial Officer
Michael Murdock
Executive Vice President, Mergers and Acquisitions
Mital Patel
Executive Vice President of Financial Planning and Analysis and Chief Administrative Officer
Norman Hames
President and Chief Operating Officer - Western Operations
Ranjan Jayanathan
Executive Vice President, Chief Information Officer
Stephen Forthuber
President and Chief Operating Officer - Eastern Operations
Board of directors at RadNet.
Research analysts who have asked questions during RadNet earnings calls.
Brian Tanquilut
Jefferies
7 questions for RDNT
Andrew Mok
Barclays
6 questions for RDNT
John Ransom
Raymond James
6 questions for RDNT
David Macdonald
Truist Securities
5 questions for RDNT
Jim Sidoti
Sidoti & Company, LLC
4 questions for RDNT
Yuan Zhi
B. Riley Financial, Inc.
4 questions for RDNT
Lawrence Solow
CJS Securities, Inc.
3 questions for RDNT
James Sidoti
Sidoti & Company
2 questions for RDNT
Larry Solow
CJS Securities
2 questions for RDNT
Brandon Carney
B. Riley
1 question for RDNT
Evan Kane
Barclays
1 question for RDNT
Grayson McAllister
Truist Securities
1 question for RDNT
Recent press releases and 8-K filings for RDNT.
- RadNet, Inc. announced on February 3, 2026, the acquisition of the outpatient imaging assets of Northwest Radiology Network, P.C., marking its entry into Indiana and expanding its presence into the Midwestern United States.
- The acquisition includes six multimodality outpatient centers in the greater Indianapolis area, with Northwest Radiology's 18 radiologists continuing to provide professional services.
- This transaction is projected to add approximately $18 million of revenue on an annualized basis to RadNet.
- RadNet operates two primary segments: Imaging Services, a $1.9 billion annual business projected to grow 11%-13% (CAGR) over the next several years, and Digital Health, which is anticipated to continue growing over 30%. The company manages 407 imaging locations and employs 11,000 individuals.
- The company is strategically focused on leveraging Artificial Intelligence (AI) to enhance efficiency, facilitate proactive prevention, and improve patient experience in healthcare. Its Digital Health segment offers 22 FDA-cleared products and 15 CE-marked solutions within the $5.1 billion (2024) market for AI-powered informatics in radiology, which is growing at 11%.
- RadNet is capitalizing on the industry trend of shifting diagnostic imaging from hospitals to lower-cost outpatient centers, where hospitals typically charge 200%-500% more. The company is expanding through 26 joint ventures with health systems, which encompass 152 of its 407 locations (37%), and recently acquired 13 centers in Florida with over $100 million in revenue.
- Financially, RadNet concluded Q3 last year with over $800 million in cash and approximately one times net leverage, expecting 100-150 basis point margin improvements from digital health solutions over the next three years.
- RadNet, the largest owner-operator of diagnostic imaging centers in the U.S., projects its imaging services division to achieve 11%-13% compound annual growth rate (CAGR) and its digital health division (DeepHealth) to grow over 30% in the coming years.
- The company is actively expanding its imaging services, including a recent acquisition on January 2nd of a Florida provider with 13 centers and over $100 million of revenue, and has 11 new centers currently in various stages of development.
- RadNet's digital health segment, DeepHealth, is a global leader in AI-powered informatics with over 2,000 external customers and 22 FDA-cleared products, anticipating 100-150 basis point margin improvements for RadNet over the next three years through its implementation.
- RadNet maintains a strong financial position, reporting over $800 million of cash and one times net leverage at the end of Q3 last year, supporting its continued investment in the business.
- RadNet projects its Imaging Services division to grow at an 11%-13% compound annual growth rate (CAGR) over the next several years, and its Digital Health division to grow over 30%. The company ended Q3 last year with over $800 million of cash and approximately one times net leverage, supporting continued investment and acquisitions.
- The company is heavily investing in artificial intelligence (AI) through its DeepHealth brand, which features 22 FDA-cleared products and 15 CE-marked solutions. This targets a radiology informatics and clinical AI market valued at $5.1 billion in 2024, growing at 11%, and is expected to drive 100-150 basis point margin improvements over the next three years.
- RadNet operates 407 locations and has 26 joint ventures with health systems, with 152 centers (37% of its total) in these partnerships, aiming to grow this to over half of its centers in the next five years. The company also recently acquired a provider in Florida with 13 centers and over $100 million of revenue.
- RadNet, Inc. announced on January 7, 2026, the acquisition of Radiology Regional, a division of LucidHealth.
- This acquisition expands RadNet's operations into Southwest Florida, adding 13 locations across Naples, Cape Coral, Fort Myers, Port Charlotte, and Sarasota.
- The acquisition is projected to add approximately $100 million of revenue to RadNet in 2026.
- Radiology Regional contributes an estimated 400 additional employees and 44 contracted radiologists to RadNet.
- RadNet reported a record third quarter with 13.4% revenue growth and 15.2% EBITDA growth year-over-year for Q3 2025, leading to increased guidance for both its imaging center business and digital health division.
- The company is strategically transforming into a technology-enabled company, leveraging AI, with its digital health division growing 51.6% in Q3 2025 and projected to achieve 30%+ annual growth.
- RadNet is pursuing aggressive expansion through acquisitions, adding 37 new imaging centers in 2024 and 29 year-to-date in 2025, alongside a strong pipeline of De Novo sites and joint ventures.
- The company anticipates continued double-digit revenue growth of 11-13% (excluding major acquisitions) and margin enhancement, supported by a strong balance sheet with over $800 million in cash and low leverage.
- RadNet reported record Q3 2025 results, with Total Company quarterly Revenue increasing 13.4% and Digital Health Revenue increasing 51.6% from Q3 2024, leading to a raised 2025 annual guidance for Imaging Center Revenue, Adjusted EBITDA, and Digital Health Revenue.
- The company maintains strong liquidity with an $804.7 million cash balance and an Adjusted EBITDA to Net Debt leverage ratio of approximately 1.0x at quarter end.
- For the 2025-2028 period, RadNet projects a Total Company Revenue CAGR of +11% to +13% and a Digital Health Revenue CAGR of ~30%, with a targeted +100bps to +150bps Adjusted EBITDA margin improvement relative to 2025.
- Key strategic initiatives, including TechLive™ for remote MRI operations, Smart Appointment Management, and the DeepHealth OS, are driving capacity expansion, operational efficiencies, and revenue growth.
- RadNet, Inc. (NASDAQ: RDNT) announced the acquisition of CIMAR UK, a leading provider of cloud-native healthcare image management solutions.
- CIMAR will be integrated into DeepHealth, RadNet’s wholly owned subsidiary, to advance connected imaging-based care.
- CIMAR's infrastructure provides data connectivity and interoperability across more than 50% of National Health Service Trusts and 80% of UK private hospital groups.
- The acquisition aims to scale digitally enabled care models across the UK and Europe, leveraging an existing partnership that has shown 76% of lung cancers detected at earlier, more treatable stages in the NHS England’s Lung Cancer Screening Program.
- RadNet, Inc. acquired the assets of Alpha RT on November 5, 2025, to create a comprehensive remote-imaging portfolio.
- The acquisition combines Alpha RT's staffing services and training programs with DeepHealth's existing FDA-cleared TechLive™ remote scanning technology.
- The expanded remote-imaging portfolio now includes DeepHealth's remote, multi-modality scanning technology, Alpha RT's AI-powered safety monitoring, remote MRI staffing services, comprehensive training, and intelligent resource optimization.
- This strategic move aims to address the challenge of rising patient demand for radiology services and a shortage of imaging technologists.
- DeepHealth's TechLive™ remote scanning technology has demonstrated a 0.06% recall rate on remote scans and a 42% reduction in MRI room closures in pilot studies.
- RadNet, the largest operator of independent freestanding imaging facilities, has achieved a 9.1% compound annual growth rate on its top line since 2007, with recent acceleration driven by a market shift towards lower-cost outpatient centers. The company expects a strong second half of 2025 and beyond, with advanced imaging growing in the mid-single digits and PET/CT growing over 15% on a same-center basis.
- The company is enhancing operational efficiency and margins through its digital health platform, DeepHealth OS, an end-to-end cloud-based operating system automating workflow and diagnostic processes. This platform is being implemented internally first to demonstrate savings before wider licensing.
- RadNet is also investing in clinical AI solutions, such as CMODE, an ultrasound AI technology that has FDA approval for thyroid ultrasound and is expected to seek approval for breast ultrasound in early 2025. This technology is projected to reduce exam times by about a third and increase capacity by 1 to 2 additional scans per machine per day.
- The company is expanding its network and capacity, with 155 of its 405 locations (over 38%) operating as hospital joint ventures, which perform slightly better than wholly-owned centers. RadNet plans to open 11 new de novo centers in 2025 and expects to spend $150 million to $160 million in CapEx this year, supported by over $800 million in cash.
Quarterly earnings call transcripts for RadNet.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more